Liver Diseases
📧 Sign up to get email alerts when something new happens for Liver Diseases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Adult-to-Adult Living Donor Transplant Cohort Study
The Clinical Trials entry indicates that the Adult-to-Adult Living Donor Transplant Cohort Study has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation
Clinical trial update reports safety system improvements for living donor liver transplantation.
-
FDA approval · 2018-07-26FDA Approved: EOVIST — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for EOVIST (gadoxetate disodium) to expand/update its labeling for MRI imaging of focal liver le…
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity [NA]
A completed University of Lausanne trial evaluating how macronutrient composition affects hepatic lipids and plasma triglycerides, as well a…
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: Effect of Terlipressin Infusion on Systemic and Hepatic Hemodynamics During Hepatobiliary Surgery [Phase 2]
Phase 2 trial assessing terlipressin infusion and its effects on systemic and hepatic hemodynamics during hepatobiliary surgery.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-04-11Clinical Trial Update: Effects of Whey Protein Consumption by Patients Waiting for Liver Transplantation [NA]
Update on a clinical trial studying the effects of whey protein consumption in patients awaiting liver transplantation.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: INR-Triggered Transfusion In GI Bleeders From ER [Phase 3]
Phase 3 trial evaluating INR-triggered transfusion in adults with gastrointestinal hemorrhage has been terminated.
-
CLINICAL_TRIALS research · 2017-03-09Clinical Trial Update: Application of 3D Visualization and 3D Printing in the Hepatobiliary and Pancreatic Surgery [NA]
This clinical trial entry describes research on using 3D visualization and 3D printing to assist hepatobiliary and pancreatic surgery, spons…
-
CLINICAL_TRIALS research · 2016-10-25Clinical Trial Update: Autologous Bone Marrow Stem Cells Infusion for the Treatment of Liver Diseases. [Phase 2]
This clinical trial update concerns a Phase 2 study of autologous bone marrow stem cell infusion as a treatment for liver diseases. The curr…
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Study of Psychological Defense Mechanisms Used by Liver Transplant Patients
An update on a completed clinical trial conducted at University Hospital, Lille. The study investigated psychological defense mechanisms amo…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases [Phase 3]
Phase 3 trial update showing completion of a study of Essentiale Paste in patients with gastrointestinal symptoms associated with acute or c…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Half-life of Plasma Phytosterols in Preterm Infants on Parenteral Nutrition
Completed clinical trial evaluating the half-life of plasma phytosterols in preterm infants receiving parenteral nutrition; results are now …
-
FDA approval · 2016-03-31FDA Approved: LUMASON — Supplemental Application (BRACCO DIAGNOSTICS INC)
FDA approves a supplemental application for Lumason (sulfur hexafluoride) from Bracco Diagnostics to expand the approved indications for ult…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers [Phase 1]
Phase 1 PK/PD study of emricasan (IDN-6556) in subjects with hepatic impairment and matched healthy volunteers has completed; results were p…
-
CLINICAL_TRIALS research · 2016-02-01Clinical Trial Update: Classical Procedure Versus Intrahepatic Glisson's Approach [NA]
Clinical trial update comparing classical procedure versus intrahepatic Glisson's approach for liver diseases; current status is not specifi…
-
CLINICAL_TRIALS research · 2016-01-06Clinical Trial Update: Spinal Versus Epidural Analgesia in Laparotomic Liver Surgery [NA]
This document reports a clinical trial comparing spinal versus epidural analgesia for patients undergoing laparotomic liver surgery; the cur…
-
CLINICAL_TRIALS research · 2015-01-14Clinical Trial Update: Sample Size Definition in Cochrane Hepato-Biliary Trials
This clinical trial update discusses standard approaches to defining sample size in randomized trials assessing liver disease within Cochran…
-
CLINICAL_TRIALS withdrawal · 2014-04-01Clinical Trial Update: Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients
A clinical trial evaluating cellular immune responses in the liver of patients with chronic hepatitis C has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-02-07Clinical Trial Update: Uncertainty Management Intervention [NA]
This is a completed clinical trial update from Duke University evaluating an uncertainty management intervention for liver diseases.
-
FDA approval · 2013-10-16FDA Approved: EOVIST — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA has approved Bayer's supplemental application for Eovist (gadoxetate disodium), updating its labeling to expand its use as an MRI co…
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)
This document reports the completion of a Special Drug Use Investigation for azathioprine (IMURAN) tablets in patients with liver diseases.
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Effect of Perioperative Sivelstat Administration for Liver Resection [NA]
A completed clinical trial evaluating perioperative administration of sivelestat during liver resection.
-
FDA approval · 2009-11-13FDA Approved: EOVIST — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for EOVIST (gadoxetate disodium) from Bayer HealthCare Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2009-05-20Clinical Trial Update: Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial [Phase 2]
A Phase 2 comparative trial evaluating induction therapy followed by immunosuppression withdrawal in liver transplantation has been terminat…
-
CLINICAL_TRIALS trial_result · 2009-02-18Clinical Trial Update: Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome [NA]
A clinical trial examining angiogenic factors in the development of hepatorenal syndrome (NCT00734136) was terminated by the sponsor (Lahey …